Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: PALLAS Laser for Skin Diseases [NA]
A clinical trial update indicating recruitment for a study evaluating the PALLAS Laser for skin diseases, including vitiligo, psoriasis, alo…
-
EMA approval · 2026-02-05EMA Authorised: Yuflyma (adalimumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Yuflyma (adalimumab) as a biosimilar of adalimumab for several inflammatory and autoimmune diseases, including rheumatoid art…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: The Effects of Audio-Based Therapy on Anxiety in Psoriasis [NA]
A clinical trial update indicates an audio-based therapy is being studied for its effects on anxiety in individuals with psoriasis, with the…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Assessing Psoriasis Treatment Outcomes [NA]
A clinical trial is planned to assess psoriasis treatment outcomes at Wake Forest University Health Sciences. The study status is not yet re…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece
A real-world study in Greece evaluating the effectiveness of risankizumab in participants with moderate plaque psoriasis. The study status i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Thera-Clean® Microbubbles System in Patients With Skin Diseases [EARLY_Phase 1]
Northwestern University is enrolling participants in an early-phase 1 trial of the Thera-Clean Microbubbles System for skin diseases, includ…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone [Phase 1]
A Phase 1 trial evaluating the combined use of cyclosporine and metformin versus cyclosporine alone for psoriasis has completed.
-
EMA approval · 2026-01-28EMA Authorised: Hukyndra (adalimumab) — Stada Arzneimittel AG
EMA authorised Hukyndra (adalimumab) from Stada Arzneimittel AG for multiple inflammatory diseases, including rheumatoid arthritis, psoriati…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
This clinical trial update describes the impact of tildrakizumab on patient-reported outcomes in adults with moderate-to-severe psoriasis in…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: CD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical Study [NA]
A completed study by Sohag University evaluating CD4+ T cells and S100A7 expression in normal versus psoriatic skin using histological and h…
-
FDA approval · 2026-01-21FDA Approved: CYCLOSPORINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's original ANDA for generic cyclosporine.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators
This clinical trial update describes research on extracting tongue and facial diagnostic features used in Traditional Chinese Medicine for p…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Topical Diacerein in Psoriasis Vulgaris [Phase 4]
A Phase 4 clinical trial is evaluating topical diacerein for psoriasis vulgaris and is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Utilization of a Microdevice for Psoriasis and Atopic Dermatitis [Phase 4]
This clinical trial update describes a Phase 4 study evaluating a microdevice for psoriasis and atopic dermatitis, with recruitment not yet …
-
EMA approval · 2026-01-19EMA Authorised: Skyrizi (risankizumab) — AbbVie Deutschland GmbH & Co. KG
The EMA authorised Skyrizi (risankizumab) for multiple indications. This expands its approved uses to psoriasis, psoriatic arthritis, ulcera…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
The LANDSCAPE study, sponsored by Fondazione ISIDE, investigates demographics and treatment patterns of patients with immune-mediated inflam…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis [Phase 1]
A Phase 1 study is evaluating the maximal usage pharmacokinetics and safety of ARQ-154 Foam 0.3% in pediatric participants with scalp and bo…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Dietary Approach to Mild-to-moderate Psoriasis [NA]
University of Palermo is recruiting for a study evaluating a dietary approach to mild-to-moderate psoriasis, including individuals with glut…
-
EMA approval · 2026-01-09EMA Authorised: Usymro (ustekinumab) — Gedeon Richter Plc.
EMA authorised Usymro (ustekinumab) by Gedeon Richter for Crohn's disease, psoriasis, and psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients [NA]
This clinical trial update notes that the study assessing fatigue in patients with psoriatic arthritis and cutaneous psoriasis has completed…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Topical SGX302 for Mild-to-Moderate Psoriasis [Phase 2]
A Phase 2 clinical trial of topical SGX302 for mild-to-moderate psoriasis has completed.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability
A clinical trial update describes a machine learning-based approach to predict insulin resistance in psoriasis patients, highlighting interp…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris
This clinical trial investigates whether variations in the vaspin gene are associated with circulating vaspin levels in individuals with pso…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial is evaluating the safety and efficacy of Lactobacillus plantarum for psoriasis;…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
The clinical trial NCT07298265 evaluating physician- versus questionnaire-based screening for psoriatic arthritis in psoriasis patients is c…